News | February 05, 2022
Expert panel recommends Emergency Use Authorisation for Sputnik Light
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce or stop transmission
The vaccines are currently only authorised for emergency use in the country
However, these won’t be available at the nearest chemist store soon
Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients
The brand is now available pan-India through their distribution partner
Covaxin has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Neutralizing antibodies in children on an average 1.7 times higher than in adults
It will be marketed under the brand name Molunamax
The Subject Expert Committee (SEC), on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) on Monday recommended granting permission to manufacture and market anti-Covid pill molnupiravir for restricted emergency use
The company has started manufacturing the Sputnik Light vaccine
Subscribe To Our Newsletter & Stay Updated
